Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 10 studies | 58% ± 25% | |
GABAergic neuron | 9 studies | 66% ± 23% | |
retinal ganglion cell | 7 studies | 81% ± 22% | |
neuron | 4 studies | 28% ± 12% | |
interneuron | 4 studies | 69% ± 25% | |
endothelial cell | 3 studies | 34% ± 14% | |
GABAergic interneuron | 3 studies | 64% ± 32% | |
amacrine cell | 3 studies | 25% ± 3% | |
GABAergic amacrine cell | 3 studies | 55% ± 7% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 11 studies | 40% ± 27% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 65% | 1238.29 | 1708 / 2642 | 55% | 4.59 | 390 / 705 |
prostate | 50% | 252.79 | 122 / 245 | 67% | 14.18 | 336 / 502 |
breast | 8% | 38.19 | 38 / 459 | 20% | 4.54 | 228 / 1118 |
liver | 2% | 2.74 | 5 / 226 | 8% | 0.24 | 32 / 406 |
adrenal gland | 0% | 0.46 | 1 / 258 | 5% | 0.44 | 12 / 230 |
skin | 0% | 0.25 | 3 / 1809 | 4% | 0.80 | 20 / 472 |
pancreas | 0% | 0 | 0 / 328 | 3% | 0.13 | 5 / 178 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.06 | 1 / 45 |
uterus | 1% | 0.96 | 1 / 170 | 2% | 0.08 | 7 / 459 |
lung | 0% | 0 | 0 / 578 | 2% | 0.11 | 22 / 1155 |
intestine | 0% | 0.11 | 1 / 966 | 2% | 0.12 | 8 / 527 |
eye | 0% | 0 | 0 / 0 | 1% | 0.07 | 1 / 80 |
bladder | 0% | 0 | 0 / 21 | 1% | 0.02 | 5 / 504 |
ovary | 0% | 0 | 0 / 180 | 1% | 0.02 | 4 / 430 |
esophagus | 0% | 0.21 | 2 / 1445 | 1% | 0.02 | 1 / 183 |
thymus | 0% | 0 | 0 / 653 | 1% | 0.01 | 4 / 605 |
stomach | 0% | 0.31 | 1 / 359 | 0% | 0.02 | 1 / 286 |
muscle | 0% | 0.14 | 1 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
adipose | 0% | 0 | 0 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0 | 0 / 1335 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
kidney | 0% | 0 | 0 / 89 | 0% | 0 | 0 / 901 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_1901381 | Biological process | positive regulation of potassium ion transmembrane transport |
GO_0051260 | Biological process | protein homooligomerization |
GO_0006813 | Biological process | potassium ion transport |
GO_0014075 | Biological process | response to amine |
GO_0032026 | Biological process | response to magnesium ion |
GO_0038060 | Biological process | nitric oxide-cGMP-mediated signaling |
GO_0099605 | Biological process | regulation of action potential firing rate |
GO_0014070 | Biological process | response to organic cyclic compound |
GO_0045471 | Biological process | response to ethanol |
GO_0071732 | Biological process | cellular response to nitric oxide |
GO_0071805 | Biological process | potassium ion transmembrane transport |
GO_0099505 | Biological process | regulation of presynaptic membrane potential |
GO_0021554 | Biological process | optic nerve development |
GO_0021759 | Biological process | globus pallidus development |
GO_0060081 | Biological process | membrane hyperpolarization |
GO_0051291 | Biological process | protein heterooligomerization |
GO_0009642 | Biological process | response to light intensity |
GO_0071242 | Biological process | cellular response to ammonium ion |
GO_0097237 | Biological process | cellular response to toxic substance |
GO_0001508 | Biological process | action potential |
GO_1990089 | Biological process | response to nerve growth factor |
GO_0016324 | Cellular component | apical plasma membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0043204 | Cellular component | perikaryon |
GO_0043195 | Cellular component | terminal bouton |
GO_0043679 | Cellular component | axon terminus |
GO_0032809 | Cellular component | neuronal cell body membrane |
GO_0042734 | Cellular component | presynaptic membrane |
GO_0030425 | Cellular component | dendrite |
GO_0098982 | Cellular component | GABA-ergic synapse |
GO_0030673 | Cellular component | axolemma |
GO_0045202 | Cellular component | synapse |
GO_0045211 | Cellular component | postsynaptic membrane |
GO_0044297 | Cellular component | cell body |
GO_0030424 | Cellular component | axon |
GO_0031982 | Cellular component | vesicle |
GO_0008076 | Cellular component | voltage-gated potassium channel complex |
GO_0032590 | Cellular component | dendrite membrane |
GO_0016323 | Cellular component | basolateral plasma membrane |
GO_0005249 | Molecular function | voltage-gated potassium channel activity |
GO_0005251 | Molecular function | delayed rectifier potassium channel activity |
GO_0099508 | Molecular function | voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential |
GO_0044325 | Molecular function | transmembrane transporter binding |
Gene name | KCNC2 |
Protein name | Potassium voltage-gated channel subfamily C member 2 (Shaw-like potassium channel) (Voltage-gated potassium channel Kv3.2) Potassium voltage-gated channel subfamily C member 2 |
Synonyms | |
Description | FUNCTION: Voltage-gated potassium channel that mediates transmembrane potassium transport in excitable membranes, primarily in the brain. Contributes to the regulation of the fast action potential repolarization and in sustained high-frequency firing in neurons of the central nervous system. Homotetramer channels mediate delayed-rectifier voltage-dependent potassium currents that activate rapidly at high-threshold voltages and inactivate slowly. Forms tetrameric channels through which potassium ions pass in accordance with their electrochemical gradient. The channel alternates between opened and closed conformations in response to the voltage difference across the membrane . Can form functional homotetrameric and heterotetrameric channels that contain variable proportions of KCNC1, and possibly other family members as well; channel properties depend on the type of alpha subunits that are part of the channel. Channel properties may be modulated either by the association with ancillary subunits, such as KCNE1, KCNE2 or KCNE3 or indirectly by nitric oxide (NO) through a cGMP- and PKG-mediated signaling cascade, slowing channel activation and deactivation of delayed rectifier potassium channels (By similarity). Contributes to fire sustained trains of very brief action potentials at high frequency in retinal ganglion cells, thalamocortical and suprachiasmatic nucleus (SCN) neurons and in hippocampal and neocortical interneurons . Sustained maximal action potential firing frequency in inhibitory hippocampal interneurons is negatively modulated by histamine H2 receptor activation in a cAMP- and protein kinase (PKA) phosphorylation-dependent manner. Plays a role in maintaining the fidelity of synaptic transmission in neocortical GABAergic interneurons by generating action potential (AP) repolarization at nerve terminals, thus reducing spike-evoked calcium influx and GABA neurotransmitter release. Required for long-range synchronization of gamma oscillations over distance in the neocortex. Contributes to the modulation of the circadian rhythm of spontaneous action potential firing in suprachiasmatic nucleus (SCN) neurons in a light-dependent manner (By similarity). . |
Accessions | ENST00000647764.1 ENST00000550433.5 [Q96PR1-2] ENST00000548513.5 [Q96PR1-3] ENST00000549446.6 [Q96PR1-1] A0A3B3ISR9 ENST00000350228.6 [Q96PR1-4] ENST00000393288.2 [Q96PR1-6] Q96PR1 ENST00000298972.5 [Q96PR1-3] ENST00000540018.5 [Q96PR1-5] |